Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Duchenne Muscular Dystrophy
Duchenne Muscular Dystrophy
Sarepta Therapeutics FDA Panel Live Blog
TheStreet.com
Mon, 04/25/16 - 08:21 am
Sarepta Therapeutics
eteplirsen
FDA
advisory panels
Duchenne Muscular Dystrophy
An Investors' Guide to Sarepta's Eteplirsen FDA Advisory Panel Meeting
TheStreet.com
Mon, 04/25/16 - 07:56 am
Sarepta Therapeutics
eteplirsen
FDA
advisory panels
Duchenne Muscular Dystrophy
Could Desperate Parents' Pleas Sway The FDA To Approve A Drug Even If Evidence It Works Is Lacking?
Forbes
Sun, 04/24/16 - 04:32 pm
FDA
parents
Duchenne Muscular Dystrophy
Sarepta Therapeutics
eteplirsen
Sarepta shares soar on FDA voting questions
CNBC
Fri, 04/22/16 - 09:38 pm
Sarepta
FDA
eteplirsen
Duchenne Muscular Dystrophy
Biotech Stock Mailbag: Is There a Future for Sarepta Therapeutics?
TheStreet.com
Fri, 04/22/16 - 10:40 am
Sarepta Therapeutics
eteplirsen
Duchenne Muscular Dystrophy
FDA Still Negative on Sarepta's DMD Drug, Stock Price Sinks
TheStreet.com
Thu, 04/21/16 - 08:45 am
FDA
Sarepta Therapeutics
Duchenne Muscular Dystrophy
eteplirsen
2 FDA Actions To Watch In April
Seeking Alpha
Mon, 03/28/16 - 09:12 pm
FDA
Sarepta Therapeutics
eteplirsen
Mycapssa
Chiasma
acromegaly
Duchenne Muscular Dystrophy
Summit develops a unique Duchenne drug for any gene mutation
Bizjournals.com
Sat, 03/26/16 - 12:59 pm
Summit Therapeutics
Sarepta Therapeutics
Duchenne Muscular Dystrophy
Sarepta surges as a group of expert doctors endorses its investigational DMD drug
Bidness, ETC
Tue, 03/22/16 - 10:00 am
physicians
Sarepta Therapeutics
Duchenne Muscular Dystrophy
eteplirsen
FDA sets new date for hearing on Sarepta’s Duchenne drug
Bizjournals.com
Thu, 03/10/16 - 09:57 am
FDA
Sarepta Therapeutics
Duchenne Muscular Dystrophy
eteplirsen
Sarepta shrinks as execs wait for FDA's decision on Duchenne drug
Fierce Biotech
Wed, 03/9/16 - 10:38 am
Sarepta Therapeutics
FDA
Duchenne Muscular Dystrophy
eteplirsen
Hope for Sarepta Drug Approval Found in Obscure FDA Document
TheStreet.com
Tue, 02/23/16 - 05:52 pm
Sarepta Therapeutics
FDA
Duchenne Muscular Dystrophy
eteplirsen
Sarepta's Duchenne drug decision delayed: Why it could help win approval
Bizjournals.com
Mon, 02/8/16 - 12:47 pm
Sarepta Therapeutics
Duchenne Muscular Dystrophy
FDA
eteplirsen
A patient in Akashi's suspended Duchenne MD trial dies
Fierce Biotech
Sat, 02/6/16 - 12:26 pm
Akashi Therapeutics
clinical trials
Duchenne Muscular Dystrophy
HT-100
Why the FDA shouldn’t bow to parental pressure over Duchenne drug
Stat
Tue, 01/26/16 - 09:17 pm
FDA
Duchenne Muscular Dystrophy
drug approvals
Biomarin
Sarepta Therapeutics
Duchenne drug by Cambridge's Catabasis looks safe in early trial
Bizjournals.com
Mon, 01/25/16 - 09:48 am
Duchenne Muscular Dystrophy
Catabasis
Forbes: There Is 'A Bit' Of Hope For Sarepta Therapeutics
Yahoo/Benzinga
Fri, 01/22/16 - 09:35 pm
Sarepta Therapeutics
eteplirsen
Duchenne Muscular Dystrophy
FDA Postpones Advisory Committee Meeting to Review Eteplirsen Due to Severe Weather Storm in the Washington D.C. Area
Yahoo
Thu, 01/21/16 - 09:38 am
FDA
advisory panels
Duchenne Muscular Dystrophy
eteplirsen
Sarepta Therapeutics
Four big problems with the FDA’s analysis of Sarepta’s Duchenne drug data
Bizjournals.com
Wed, 01/20/16 - 09:31 pm
FDA
Sarepta Therapeutics
Duchenne Muscular Dystrophy
eteplirsen
Duchenne mom: FDA is ‘looking for reasons to deny’ Sarepta’s drug
Bizjournals.com
Fri, 01/15/16 - 02:28 pm
FDA
Sarepta Therapeutics
eteplirsen
Duchenne Muscular Dystrophy
Pages
« first
‹ previous
…
9
10
11
12
13
14
15
16
17
…
next ›
last »